Mike Polark
Stock Analyst at Baird
(2.16)
# 2,817
Out of 5,179 analysts
87
Total ratings
40.35%
Success rate
-2.7%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Maintains: Outperform | $220 → $200 | $118.10 | +69.35% | 14 | Feb 20, 2026 | |
| INSP Inspire Medical Systems | Downgrades: Peer Perform | n/a | $50.13 | - | 11 | Feb 13, 2026 | |
| MDLN Medline | Initiates: Outperform | $47 | $41.36 | +13.64% | 1 | Jan 12, 2026 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $79.34 | - | 5 | Oct 29, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $87.14 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $10.76 | +85.87% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $61.85 | -2.99% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $208.22 | +68.09% | 4 | May 13, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $19.46 | +49.02% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $220.47 | -18.36% | 5 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $88.57 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $327.44 | +23.69% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $452.66 | +11.12% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $103.99 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $116.22 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $62.25 | +94.38% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $21.00 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $13.13 | +90.40% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $177.11 | -6.84% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $69.17 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $13.34 | -2.55% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $2.82 | +644.68% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $219.40 | +13.95% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.14 | +3,671.93% | 1 | Sep 2, 2020 |
iRhythm Holdings
Feb 20, 2026
Maintains: Outperform
Price Target: $220 → $200
Current: $118.10
Upside: +69.35%
Inspire Medical Systems
Feb 13, 2026
Downgrades: Peer Perform
Price Target: n/a
Current: $50.13
Upside: -
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $47
Current: $41.36
Upside: +13.64%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $79.34
Upside: -
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $87.14
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $10.76
Upside: +85.87%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $61.85
Upside: -2.99%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $208.22
Upside: +68.09%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $19.46
Upside: +49.02%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $220.47
Upside: -18.36%
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $88.57
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $327.44
Upside: +23.69%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $452.66
Upside: +11.12%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $103.99
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $116.22
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $62.25
Upside: +94.38%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $21.00
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $13.13
Upside: +90.40%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $177.11
Upside: -6.84%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $69.17
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $13.34
Upside: -2.55%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $2.82
Upside: +644.68%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $219.40
Upside: +13.95%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.14
Upside: +3,671.93%